Tae-Sung Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tae-Sung Ko has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
Mi-Sun Yum
35 shared publications- Mi-Sun Yum
Department of Pediatrics University of Ulsan College of Medicine Seoul South Korea
22 shared publications Eun-Hee Kim
Department of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul, South Korea
14 shared publications- Min-Jee Kim
Department of Biochemistry and Molecular Biology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
8 shared publications Eun Hye Lee
7 shared publicationsHan-Wook Yoo
Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea
7 shared publications
Latest Publications
- 24 July 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 142, 8-17
A clinical nomogram for predicting drug-resistant epilepsy and its long-term persistence in children: a cohort study
- 24 July 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 142, 8-17
A clinical nomogram for predicting drug-resistant epilepsy and its long-term persistence in children: a cohort study
- 28 July 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 131, 265-274
Alpha-ERSP as a prognostic biomarker in infantile epileptic spasms syndrome: Insights from quantitative EEG analysis
- 28 July 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 131, 265-274
Alpha-ERSP as a prognostic biomarker in infantile epileptic spasms syndrome: Insights from quantitative EEG analysis
- 15 July 2025
- Published by Elsevier in Epilepsy Research
- Vol. 217, 107622
Childhood-onset epilepsy: Longitudinal seizure outcomes in a large single-center cohort
- 15 July 2025
- Published by Elsevier in Epilepsy Research
- Vol. 217, 107622
Childhood-onset epilepsy: Longitudinal seizure outcomes in a large single-center cohort
- 14 January 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (1) , e210178
Child Neurology: Neurophysiologic and Anatomical Correlates in Startle Epilepsy
Startle epilepsy, characterized by startle-provoked epileptic seizures, was historically recognized as one of the reflex epilepsies but currently lacks classification as a specific epileptic syndrome because of insufficient characterization. This study presents an institutional experience and review of relevant literature focusing on the neurophysiologic and anatomical aspects of startle epilepsy. We describe a pediatric patient with an underlying structural etiology of left frontal encephalomalacia who continued to experience disabling seizures despite multiple antiseizure medications and previous palliative surgery. A comprehensive presurgical evaluation using SEEG led to the resection of the left supplementary motor area and adjacent middle cingulate cortex, resulting in successful seizure remission. A literature review on the surgical treatment of startle epilepsy revealed consistent reports of successful seizure remission through neocortical resection of the supplementary motor area and/or cingulate region. This case study and literature review highlights startle epilepsy as a distinct form of epilepsy with identifiable neurophysiologic and anatomical characteristics. Our observations emphasize the potential of resective surgery as a viable treatment option for startle epilepsy and underscore the importance of neurophysiologic monitoring in guiding surgical interventions.
- 14 January 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (1) , e210178
Child Neurology: Neurophysiologic and Anatomical Correlates in Startle Epilepsy
Startle epilepsy, characterized by startle-provoked epileptic seizures, was historically recognized as one of the reflex epilepsies but currently lacks classification as a specific epileptic syndrome because of insufficient characterization. This study presents an institutional experience and review of relevant literature focusing on the neurophysiologic and anatomical aspects of startle epilepsy. We describe a pediatric patient with an underlying structural etiology of left frontal encephalomalacia who continued to experience disabling seizures despite multiple antiseizure medications and previous palliative surgery. A comprehensive presurgical evaluation using SEEG led to the resection of the left supplementary motor area and adjacent middle cingulate cortex, resulting in successful seizure remission. A literature review on the surgical treatment of startle epilepsy revealed consistent reports of successful seizure remission through neocortical resection of the supplementary motor area and/or cingulate region. This case study and literature review highlights startle epilepsy as a distinct form of epilepsy with identifiable neurophysiologic and anatomical characteristics. Our observations emphasize the potential of resective surgery as a viable treatment option for startle epilepsy and underscore the importance of neurophysiologic monitoring in guiding surgical interventions.
- Open Access
- 1 November 2024
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 67 (6) , 661-674
Clinical Applicability and Safety of Conventional Frame-Based Stereotactic Techniques for Stereoelectroencephalography
Objective : Stereoelectroencephalography (SEEG) is increasingly being recognized as an important invasive modality for presurgical evaluation of epilepsy. This study focuses on the clinical and technical considerations of SEEG investigations when using conventional frame-based stereotaxy, drawing on institutional experience and a comprehensive review of relevant literature.Methods : This retrospective observational study encompassed the surgical implantation of 201 SEEG electrodes in 16 epilepsy patients using a frame-based stereotactic instrument at a single tertiary-level center. We provide detailed descriptions of the operative procedures and technical nuances for bilateral and multiple SEEG insertions, along with several illustrative cases. Additionally, we present a literature review on the technical aspects of the SEEG procedure, discussing its clinical implications and potential risks.Results : Frame-based SEEG electrode placements were successfully performed through sagittal arc application, with the majority (81.2%) of cases being bilateral and involving up to 18 electrodes in a single operation. The median skin-to-skin operation time was 162 minutes (interquartile range [IQR], 145–200), with a median of 13 minutes (IQR, 12–15) per electrode placement for time efficiency. There were two occurrences (1.0%) of electrode misplacement and one instance (0.5%) of a postoperative complication, which manifested as a delayed intraparenchymal hemorrhage. Following SEEG investigation, 11 patients proceeded with surgical intervention, resulting in favorable seizure outcomes for nine (81.8%) and complete remission for eight cases (72.7%).Conclusion : Conventional frame-based stereotactic techniques remain a reliable and effective option for bilateral and multiple SEEG electrode placements. While SEEG is a suitable approach for selected patients who are strong candidates for epilepsy surgery, it is important to remain vigilant concerning the potential risks of electrode misplacement and hemorrhagic complications.
- 1 November 2024
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 67 (6) , 661-674
Open AccessClinical Applicability and Safety of Conventional Frame-Based Stereotactic Techniques for Stereoelectroencephalography
Objective : Stereoelectroencephalography (SEEG) is increasingly being recognized as an important invasive modality for presurgical evaluation of epilepsy. This study focuses on the clinical and technical considerations of SEEG investigations when using conventional frame-based stereotaxy, drawing on institutional experience and a comprehensive review of relevant literature.Methods : This retrospective observational study encompassed the surgical implantation of 201 SEEG electrodes in 16 epilepsy patients using a frame-based stereotactic instrument at a single tertiary-level center. We provide detailed descriptions of the operative procedures and technical nuances for bilateral and multiple SEEG insertions, along with several illustrative cases. Additionally, we present a literature review on the technical aspects of the SEEG procedure, discussing its clinical implications and potential risks.Results : Frame-based SEEG electrode placements were successfully performed through sagittal arc application, with the majority (81.2%) of cases being bilateral and involving up to 18 electrodes in a single operation. The median skin-to-skin operation time was 162 minutes (interquartile range [IQR], 145–200), with a median of 13 minutes (IQR, 12–15) per electrode placement for time efficiency. There were two occurrences (1.0%) of electrode misplacement and one instance (0.5%) of a postoperative complication, which manifested as a delayed intraparenchymal hemorrhage. Following SEEG investigation, 11 patients proceeded with surgical intervention, resulting in favorable seizure outcomes for nine (81.8%) and complete remission for eight cases (72.7%).Conclusion : Conventional frame-based stereotactic techniques remain a reliable and effective option for bilateral and multiple SEEG electrode placements. While SEEG is a suitable approach for selected patients who are strong candidates for epilepsy surgery, it is important to remain vigilant concerning the potential risks of electrode misplacement and hemorrhagic complications.
- Open Access
- 1 January 2024
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 32 (1) , 57-61
Profound Biotinidase Deficiency: A Rare but Treatable Inborn Error of Metabolism in a Neonate with Recurrent Seizures
- 1 January 2024
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 32 (1) , 57-61
Open AccessProfound Biotinidase Deficiency: A Rare but Treatable Inborn Error of Metabolism in a Neonate with Recurrent Seizures
- Open Access
- 1 April 2023
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 31 (2) , 113-122
Long-Term Pharmacological and Psychosocial Outcomes of Adolescent-Onset Epilepsy: A Single-Center Experience
Purpose: Despite the high incidence of epilepsy during adolescence, little attention has been paid to the outcomes and prognosis of adolescent-onset epilepsy. The aim of this study was to investigate the long-term pharmacological and psychosocial outcomes of adolescent-onset epilepsy.Methods: From 1993 to 2019, the electronic medical records of adolescent-onset epilepsy patients were retrieved from Asan Medical Center Children’s Hospital. Seizure outcomes were evaluated based on the seizure-free period at last contact. Possible predictors of remission, relapse, and intractability were investigated. Neuropsychiatric comorbidities, socioeconomic status, and transition outcomes were also assessed. Results: In total, 137 patients were enrolled in this study. The median age at diagnosis of epilepsy was 14 years and the mean duration of therapy was 13.0 years. During follow-up, 93 patients (67.9%) achieved terminal remission, of which 27 cases (19.7%) resolved. Relapse after withdrawal of medication occurred in 74 patients (54.0%), and the presence of electroencephalographic abnormalities (odds ratio [OR], 8.23; 95% confidence interval [CI], 1.39 to 48.87; P=0.020), poor adherence (OR, 4.84; 95% CI, 2.13 to 11.02; P=0.000), and history of febrile seizures (OR, 4.10; 95% CI, 1.21 to 13.93; P=0.024) were risk factors for relapse. Neurodevelopmental and psychological comorbidities were documented in 17 (12.4%) and 12 (8.8%) patients, respectively. Thirty-six (26.3%) patients transferred to adult clinics, at a mean age of 21.9 years. Conclusion: This study showed overall favorable seizure outcomes with a high rate of remission, but with frequent relapse after withdrawal.
- 1 April 2023
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 31 (2) , 113-122
Open AccessLong-Term Pharmacological and Psychosocial Outcomes of Adolescent-Onset Epilepsy: A Single-Center Experience
Purpose: Despite the high incidence of epilepsy during adolescence, little attention has been paid to the outcomes and prognosis of adolescent-onset epilepsy. The aim of this study was to investigate the long-term pharmacological and psychosocial outcomes of adolescent-onset epilepsy.Methods: From 1993 to 2019, the electronic medical records of adolescent-onset epilepsy patients were retrieved from Asan Medical Center Children’s Hospital. Seizure outcomes were evaluated based on the seizure-free period at last contact. Possible predictors of remission, relapse, and intractability were investigated. Neuropsychiatric comorbidities, socioeconomic status, and transition outcomes were also assessed. Results: In total, 137 patients were enrolled in this study. The median age at diagnosis of epilepsy was 14 years and the mean duration of therapy was 13.0 years. During follow-up, 93 patients (67.9%) achieved terminal remission, of which 27 cases (19.7%) resolved. Relapse after withdrawal of medication occurred in 74 patients (54.0%), and the presence of electroencephalographic abnormalities (odds ratio [OR], 8.23; 95% confidence interval [CI], 1.39 to 48.87; P=0.020), poor adherence (OR, 4.84; 95% CI, 2.13 to 11.02; P=0.000), and history of febrile seizures (OR, 4.10; 95% CI, 1.21 to 13.93; P=0.024) were risk factors for relapse. Neurodevelopmental and psychological comorbidities were documented in 17 (12.4%) and 12 (8.8%) patients, respectively. Thirty-six (26.3%) patients transferred to adult clinics, at a mean age of 21.9 years. Conclusion: This study showed overall favorable seizure outcomes with a high rate of remission, but with frequent relapse after withdrawal.
- Open Access
- 1 January 2023
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 31 (1) , 20-26
Cannabidiol Treatment for Lennox-Gastaut Syndrome at a Single Tertiary Center in South Korea
Purpose: This study evaluated the efficacy and tolerability of cannabidiol (CBD) as an add-on therapy for childhood-onset Lennox-Gastaut syndrome (LGS).Methods: This retrospective study enrolled patients who visited the Department of Pediatric Neurology at Asan Medical Center from March 2019 to February 2022 and were treated with CBD. Electronic medical records and clinically relevant factors (including the type of epilepsy and seizures, etiology, and the number of concomitantly used anti-epileptic drugs) were reviewed. The outcome was clinical response to CBD (≥50% or 3 years) was associated with a favorable response to CBD treatment. Further prospective studies with larger populations are needed to evaluate the tolerability and efficacy of CBD in patients with drug-resistant epilepsy of various etiologies.
- 1 January 2023
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 31 (1) , 20-26
Open AccessCannabidiol Treatment for Lennox-Gastaut Syndrome at a Single Tertiary Center in South Korea
Purpose: This study evaluated the efficacy and tolerability of cannabidiol (CBD) as an add-on therapy for childhood-onset Lennox-Gastaut syndrome (LGS).Methods: This retrospective study enrolled patients who visited the Department of Pediatric Neurology at Asan Medical Center from March 2019 to February 2022 and were treated with CBD. Electronic medical records and clinically relevant factors (including the type of epilepsy and seizures, etiology, and the number of concomitantly used anti-epileptic drugs) were reviewed. The outcome was clinical response to CBD (≥50% or 3 years) was associated with a favorable response to CBD treatment. Further prospective studies with larger populations are needed to evaluate the tolerability and efficacy of CBD in patients with drug-resistant epilepsy of various etiologies.
- 6 April 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 98, 95-100
Cleft size and type are associated with development of epilepsy and poor seizure control in patients with schizencephaly
- 6 April 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 98, 95-100
Cleft size and type are associated with development of epilepsy and poor seizure control in patients with schizencephaly
- Open Access
Hematopoietic Stem Cell Transplantation-Associated Neurological Complications and Their Brain MR Imaging Findings in a Pediatric Population
Purpose: To determine the prognostic indicators for hematopoietic stem cell transplantation (HSCT)-associated neurological complications, the clinical characteristics and brain magnetic resonance imaging (MRI) lesions in pediatric HSCT recipients were reviewed. Methods: This retrospective study included 51 patients who had underwent a brain MRI due to newly developed neurological symptoms or infection signs during chemotherapy or HSCT. We reviewed the demographics, received treatments, treatment-related morbidities, laboratory findings and brain MRI findings, which were compared between good and poor neurologic outcome groups. Results: Thirty-seven patients (72.5%) fully recovered from the neurologic deficits and fourteen (27.5%) persisted or aggravated. The children with an underlying malignant disease had significantly poorer neurological outcomes (p = 0.015). The neurologic complications associated with infection were more frequent in the poor outcome group (p = 0.038). In the neuroimaging findings, the extent of the white matter lesions was significantly higher in the poor outcome group, as was that of abnormal enhancement, ventriculomegaly, cortical change, deep gray matter abnormalities and cerebellar abnormalities. Conclusion: Most children with neurologic complications and neuroimaging abnormalities during HSCT had recovered. However, children with neurologic complications associated with infectious causes, malignant disease or severe brain MRI abnormalities should be more carefully monitored during HSCT.
Open AccessHematopoietic Stem Cell Transplantation-Associated Neurological Complications and Their Brain MR Imaging Findings in a Pediatric Population
Purpose: To determine the prognostic indicators for hematopoietic stem cell transplantation (HSCT)-associated neurological complications, the clinical characteristics and brain magnetic resonance imaging (MRI) lesions in pediatric HSCT recipients were reviewed. Methods: This retrospective study included 51 patients who had underwent a brain MRI due to newly developed neurological symptoms or infection signs during chemotherapy or HSCT. We reviewed the demographics, received treatments, treatment-related morbidities, laboratory findings and brain MRI findings, which were compared between good and poor neurologic outcome groups. Results: Thirty-seven patients (72.5%) fully recovered from the neurologic deficits and fourteen (27.5%) persisted or aggravated. The children with an underlying malignant disease had significantly poorer neurological outcomes (p = 0.015). The neurologic complications associated with infection were more frequent in the poor outcome group (p = 0.038). In the neuroimaging findings, the extent of the white matter lesions was significantly higher in the poor outcome group, as was that of abnormal enhancement, ventriculomegaly, cortical change, deep gray matter abnormalities and cerebellar abnormalities. Conclusion: Most children with neurologic complications and neuroimaging abnormalities during HSCT had recovered. However, children with neurologic complications associated with infectious causes, malignant disease or severe brain MRI abnormalities should be more carefully monitored during HSCT.